FPF Workshop 2019: Non-monotonicity explained

Ana Soto presents biological mechanisms underlying non-monotonic dose-responses, explains why non-monotonicity is ‘useful to organisms, challenging for regulators,’ discusses CLARITY-BPA’s successes and limitations

Meta-analysis of BPA’s link to diabetes

Meta-analysis of epidemiological studies finds positive association between BPA exposure and type 2 diabetes risk

Chemicals in plastics and obesity

U.S. researchers discuss contribution of exposure to endocrine disruptors to metabolic disorders such as obesity and diabetes

Can chemicals lead to weight gain?

Podcast highlights role of obesogenic chemicals in obesity epidemic with leading scientist in the field; other academics remain skeptical of impact of obesogens

Webinar on metabolic disruptors

Prof. Dr. Bruce Blumberg discusses chemicals that can interfere with the body’s fat metabolism in webinar hosted by Collaborative on Health and the Environment (CHE) on March 21, 2018

Alternative plasticizers adipogenic in vitro

Several alternative plasticizers used in FCMs shown to promote lipid accumulation in vitro; direct activation of PPARγ suggested as possible mechanism

PFASs linked to weight gain

New study by Harvard scientists finds association between higher PFASs blood levels and greater weight gain after dieting; high PFASs levels also linked to low resting metabolic rates

Obesity increased tenfold in children and teens

New WHO study finds worldwide rise in childhood and teen obesity between 1975 and 2016; NGO discusses metabolic disruptors as contributing factor to obesity epidemic

More evidence on hazard potential of BPA and BPS

Endocrine Society highlights 3 scientific studies investigating effects of bisphenol A and its common substitute bisphenol S on body weight, liver development, and breast cancer

Scientific statement on obesity

Endocrine Society issues statement on causes of obesity, highlights biological process governing weight stability, calls for more research on factors influencing obesity such as endocrine disruptors